InMed Pharmaceuticals Profile

0.62
USD 0.07  13.50%
32%
66%

InMed Pharmaceuticals Summary

InMed Pharmaceuticals (IMLFF) is traded on OTC Market in USA. It is located in 409 Granville Street and employs 4 people. The company currently falls under 'Small-Cap' category with current market capitalization of 101.47 M. InMed Pharmaceuticals classifies itself under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. This company has 152.79 M outstanding shares. INMED PHARMACEUTI has accumulated about 19.88 M in cash with (3.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12.
Check InMed Pharmaceuticals Probability Of Bankruptcy

InMed Pharmaceuticals Target Price Odds Analysis

Odds Below 0.62HorizonTargetOdds Above 0.62
44.36%30 days 0.62 55.48%
Based on normal probability distribution, the odds of InMed Pharmaceuticals to move above current price in 30 days from now is about 55.48% (This InMed Pharmaceuticals probability density function shows the probability of InMed Pharmaceuticals Stock to fall within a particular range of prices over 30 days) .

InMed Pharmaceuticals Risk Profiles

InMed Pharmaceuticals Key Fundamentals

InMed Pharmaceuticals Against Markets

InMed Pharmaceuticals Current Ratings

InMed Pharmaceuticals 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
95 
Equity ratings for InMed Pharmaceuticals are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
InMed Pharmaceuticals Inc., a pre-clinical stage biopharmaceutical company, researches and develops novel and cannabinoid-based therapies. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada. InMed Pharmaceuticals operates under Drug Manufacturers - Specialty Generic classification in USA and traded on OTC Market. It employs 4 people. more
NameInMed Pharmaceuticals
CEOCraig SchneiderView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address409 Granville Street
ExchangeOTC Market
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
BenchmarkDOW
Websitewww.inmedpharma.com
Phone604 669 7207
CurrencyUSD - US Dollar
Next Fiscal Year EndJune 30, 2020
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndJune 30, 2018

InMed Pharmaceuticals Directors

InMed Pharmaceuticals Corporate Directors

Andrew Hullh Director
Andrew Hull Director
William Garner Director
Please also check Risk vs Return Analysis. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Search macroaxis.com